Suchergebnisse - "Ghelardi, Filippo"

PubPharm (11)

1

Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Hedayat, S. | Cascione, L. | Cunningham, D. | +43

2

Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas : A literature review with expert opinion

enthalten in: Pathology, research and practice | 2024

von Angerilli, V. | Ghelardi, F. | Nappo, F. | +8

3

Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade : the PRESSING-HER2 Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Randon, G. | Nakamura, Y. | Yaeger, R. | +19

CommentIn: Clin Cancer Res. 2024 Jan 17;30(2):260-262. - PMID 37975903

4

Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin

enthalten in: Clinical colorectal cancer | 2023

von Ghelardi, F. | Raimondi, A. | Morano, F. | +18

5

Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Pietrantonio, F. | Bergamo, F. | Rossini, D. | +17

6

Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy

enthalten in: JCO precision oncology | 2023

von Moretto, R. | Germani, M. | Ros, J. | +17

7

Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Manca, P. | Corti, F. | Intini, R. | +17

8

Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

enthalten in: Journal for immunotherapy of cancer | 2023

von Randon, G. | Aoki, Y. | Cohen, R. | +20

9

Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Bergen, E. | Pilla, L. | Auclin, E. | +21

10

Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma—a retrospective, international, multicentric AGEO study

enthalten in: Gastric cancer | 2023

von Bergen, E. | Pilla, L. | Auclin, E. | +21